Convatec Group (FRA:2CV) Tariff Resilience Score: 5/10 (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2CV Convatec Group PLC FRA:2CV
80 GF Score
Price €2.54
GF Value €2.89
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Convatec Group Tariff Resilience Score?

Convatec Group FRA:2CV -0.79% 80 Tariff Resilience Score is 5 as of Sep. 22, 2026. GuruFocus rates FRA:2CV with a GF Score™ of 80/100 and a GF Value™ of €2.89 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 825 Medical Devices & Instruments companies, Convatec Group ranks better than 79.03% on this metric.

Convatec Group has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Convatec Group has Moderate exposure due to global supply chain and sales markets. Historical tariff impacts have been significant, but mitigated through strategic supplier diversification. Industry faces specific challenges.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Convatec Group might have Average Resilient.

Convatec Group  (FRA:2CV) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Convatec Group Tariff Resilience Score Related Terms

FRA:2CV vs ISRG, BDX, RMD: Tariff Resilience Score Comparison

For the Medical Instruments & Supplies subindustry, Convatec Group's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Convatec Group Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Convatec Group's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Convatec Group's Tariff Resilience Score falls into.


FRA:2CV
80GF Score
Convatec Group PLC FRA:2CV
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Convatec Group (FRA:2CV) has a Tariff Resilience Score of 5 as of Sep. 22, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Convatec Group ranks #173 out of 825 companies in the Medical Devices & Instruments industry, placing it in the top 21%.
Is Convatec Group's Tariff Resilience Score too high?
Convatec Group's current Tariff Resilience Score is 5. Based on the distribution chart, Convatec Group ranks #173 out of 825 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Convatec Group has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Convatec Group's Tariff Resilience Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Convatec Group ranks #173 out of 825 companies for Tariff Resilience Score. This places Convatec Group in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Convatec Group's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Convatec Group stock overvalued right now?
Based on GuruFocus' analysis, Convatec Group (FRA:2CV) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.89, compared to a current price of €2.54 — trading 12.1% below its estimated fair value. The current Tariff Resilience Score is 5. Convatec Group's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Convatec Group (FRA:2CV), the current Tariff Resilience Score is 5 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Convatec Group (FRA:2CV) Overvalued in 2026?

Based on GuruFocus' analysis, Convatec Group stock appears to be undervalued. The current stock price of €2.54 is trading 12.1% below its estimated GF Value™ of €2.89. GuruFocus considers Convatec Group to be Modestly Undervalued.

Key valuation signals for FRA:2CV:

  • Tariff Resilience Score: 5
  • GF Value™: €2.89 vs. price of €2.54 (12.1% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the FRA:2CV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Convatec Group Business Description

Address 20 Eastbourne Terrace, 7th Floor, London, GBR, W2 6LG
Convatec Group PLC is a medical products company focused on chronic care, serving patients and healthcare providers in hospital and home settings. It operates across four main categories: advanced wound care, ostomy care, continence care, and infusion care. Its products include dressings and skin care for wound management, ostomy pouches and accessories, continence and urology products, and infusion sets and devices for diabetes and other therapies. The company sells primarily to hospitals, clinics, home healthcare providers, and directly to patients, with revenue generated through the sale of consumable medical products and related accessories. Convatec operates globally, with significant revenue from North America, Europe, and other international markets, and maintains manufacturing and research facilities in multiple countries. The business emphasizes recurring revenue from consumable products used in ongoing patient care.
80GF Score

Get the complete analysis for FRA:2CV

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.54
Price
€2.89
GF Value